-
NMPA Issued the Announcement on Medical Device GMP Appendix: Independent Software
2019-07-12
NMPA organized the drafting of and released on July 12, 2019 the Medical Device GMP Appendix: Independent Software.
-
NMPA Issued the Announcement on the Requirements for Filing Review of Registration Items of Medical Device Products (Interim)
2019-07-10
NMPA organized the formulation of the Requirements for Filing Review of Registration Items of Medical Device Products (Interim), which has been released on July 10, 2019, and shall enter into force as from September 1, 2019.
-
Provisions for Supervision of Drug Distribution
2019-07-25
The Provisions for Supervision of Drug Distribution, adopted at the executive meeting of the State Food and Drug Administration on December 8, 2006, is hereby promulgated and shall go into effect as of May 1, 2007.
-
Provisions for Medical Device Registration (Abolished)
2019-07-25
The Provisions for Medical Device Registration, adopted at the executive meeting of China Food and Drug Administration on June 27, 2014, is hereby promulgated and shall be effective as of October 1, 2014.
-
Provisions for In-vitro Diagnostic Reagent Registration (Abolished)
2019-07-25
The Provisions for In-vitro Diagnostic Reagent Registration, adopted at the executive meeting of China Food and Drug Administration on June 27, 2014, is hereby promulgated and shall be effective as of October 1, 2014.
-
Provisions for Drug Registration (Abolished)
2019-07-25
The Provisions are formulated for the purposes of ensuring the safety, efficacy and quality of drugs and regulating drug registration in accordance with the Drug Administration Law of the People's Republic of China, Administrative Permission Law of the People's Republic of China and the Regulations for Implementation of the Drug Administration Law of the People's Republic of China.